High Id1 expression is associated with poor prognosis in 237 patients with acute myeloid leukemia

High BAALC expression associates with other molecular prognostic markers, poor outcome, and a distinct gene-expression signature in cytogenetically normal patients younger than 60 years with acute myeloid leukemia: a Cancer and Leukemia Group B (CALGB) study

(2008) C. Langer et al.   BLOOD

Id1 is a common downstream target of oncogenic tyrosine kinases in leukemic cells

(2008) W. F. Tam et al.   BLOOD

The Helix-Loop-Helix Protein Id1 Requires Cyclin D1 to Promote the Proliferation of Mammary Epithelial Cell Acini

(2008) C. E. Caldon et al.   CANCER RESEARCH

Regulation of Id1 Expression by Src: Implications for Targeting of the Bone Morphogenetic Protein Pathway in Cancer

(2008) O. Gautschi et al.   CANCER RESEARCH

Targeting Ras in Myeloid Leukemias

(2008) B. S. Braun et al.   CLINICAL CANCER RESEARCH

Mutations and Treatment Outcome in Cytogenetically Normal Acute Myeloid Leukemia

(2008) Richard F. Schlenk et al.   NEW ENGLAND JOURNAL OF MEDICINE

Id1 immortalizes hematopoietic progenitors in vitro and promotes a myeloproliferative disease in vivo

(2008) H C Suh et al.   ONCOGENE

Id1 cooperates with oncogenic Ras to induce metastatic mammary carcinoma by subversion of the cellular senescence response

(2008) A. Swarbrick et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA